Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Cantargia to Participate in Upcoming Investor Conferences
Healthcare & PharmaceuticalCompany Update

Cantargia to Participate in Upcoming Investor Conferences

August 28, 2026 5:20 AM

Cantargia AB (publ) (Nasdaq Stockholm:CANTA) today announced that management will participate in the following investor conferences during September 2026. H.C. Wainwright - 28th Annual Global Investment Conference 2026, New York Company Presentation by Hilde Steineger, CEO Investor meetings September 14 at 10.30 am ET (16.30pm CEST). Biostock - Investing in Life Sciences, IVA Konferens, Stockholm Presentation by Hilde Steineger, CEO September 22...

Read more
MemoryFlow Review 2026: Could This 12-Minute Audio Be the Memory-Support Upgrade Your Daily Routine Has Been Missing?
Healthcare & PharmaceuticalAdvertorial

MemoryFlow Review 2026: Could This 12-Minute Audio Be the Memory-Support Upgrade Your Daily Routine Has Been Missing?

August 27, 2026 9:55 PM

Disclaimers: This is a paid advertorial, and a commission is earned if you buy through links here. Claims below are attributed to the brand, not independently endorsed by this publication. MemoryFlow is marketed as a digital audio wellness product - no FDA clearance, approval, or authorization was confirmed in the materials reviewed, this article doesn't independently classify it under FDA medical-device rules, and per the brand's own disclaimer...

Read more
Midi Health Supplements Review 2026: Is This the Midlife Wellness Line Worth Adding to Your Daily Routine?
Healthcare & PharmaceuticalAdvertorial

Midi Health Supplements Review 2026: Is This the Midlife Wellness Line Worth Adding to Your Daily Routine?

August 27, 2026 9:35 PM

Advertorial Disclosure: This article contains sponsored content and affiliate links. Compensation may be received if you purchase through links in this article. This is not medical advice, and the views expressed do not constitute an endorsement by this publication. Check current Midi Health Supplements product information here Midi Health Supplements Consumer Research 2026: Researching Ingredients, Prices & Reviews So you've seen Midi Health's...

Read more
Emerging Growth Research Issues Updated Press Release Announcing Company-Sponsored Research on SBC Medical Group Holdings Incorporated
Healthcare & PharmaceuticalCompany Update

Emerging Growth Research Issues Updated Press Release Announcing Company-Sponsored Research on SBC Medical Group Holdings Incorporated

August 27, 2026 5:30 PM

Emerging Growth Research, LLC ("Emerging Growth Research" or "EGR") today announced the release of its company-sponsored research quarterly update on SBC Medical Group Holdings Incorporated (NASDAQ:SBC), which, together with its subsidiaries, provides management services to cosmetic treatment centers via a franchise model in Japan, Vietnam, Thailand, Singapore, and the United States. This release is being issued as an updated version of EGR's...

Read more
Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines
Healthcare & PharmaceuticalCompany Update

Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines

August 27, 2026 3:56 PM

Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Applications (sBLA) for the 2026-2027 formulas for Spikevax® (COVID-19 Vaccine, mRNA) and mNEXSPIKE® (COVID-19 Vaccine, mRNA), containing the JN.1-lineage XFG subvariant of SARS-CoV-2 to help prevent COVID-19. The updated formula for Spikevax is now approved for individuals 6 months through 64 years of age...

Read more
Sokol Advanced EyeCare Expands Dry Eye and Ocular Wellness Services with Tixel Technology
Healthcare & PharmaceuticalCompany Update

Sokol Advanced EyeCare Expands Dry Eye and Ocular Wellness Services with Tixel Technology

August 27, 2026 2:50 PM

Sokol Advanced EyeCare, a leading private optometric practice specializing in ocular wellness and dry eye disease, today announced the addition of Tixel for Dry Eye and Tixel for Youthful Eyes to its growing portfolio of advanced treatment technologies. The investment reinforces the practice's commitment to delivering evidence-based care and innovative solutions for patients throughout the Madison community. With Tixel for Dry Eye and Tixel for...

Read more
How Avel eCare's Virtual Health System Helps Rural Physicians Stay in Their Communities
Healthcare & PharmaceuticalAdvertorial

How Avel eCare's Virtual Health System Helps Rural Physicians Stay in Their Communities

August 27, 2026 1:00 PM

When a massive explosion happened in a small rural town, the local hospital suddenly faced a situation that would challenge even a large trauma center. Five burn patients were on the way. For the physician working that shift, the moment was especially overwhelming. She was a traveling physician-not a full-time emergency medicine specialist-and she was covering in her hometown community. Dr. Kelly Rhone, Chief Medical Officer at Avel eCare,...

Read more
D.C. Circuit Moves Forward With MMJ Appeal Challenging CMS Hemp Program
Healthcare & PharmaceuticalCompany Update

D.C. Circuit Moves Forward With MMJ Appeal Challenging CMS Hemp Program

August 27, 2026 10:10 AM

The U.S. Court of Appeals for the District of Columbia Circuit has entered a briefing schedule in Smart Approaches to Marijuana, et al. v. Kennedy, No. 26-5205, the appeal challenging the Centers for Medicare & Medicaid Services' Substance Access Beneficiary Engagement Incentive. MMJ International Holdings, Inc. and its subsidiaries are among the appellants. Entered on the court's own motion August 26, 2026: Appellants' Brief - October 5,...

Read more
PRM Cosmetic Surgery Announces New Surgeon Training Initiative Led by Dr. Robert Rey
Healthcare & PharmaceuticalCompany Update

PRM Cosmetic Surgery Announces New Surgeon Training Initiative Led by Dr. Robert Rey

August 27, 2026 10:00 AM

PRM Cosmetic Surgery today announced a new surgeon-training initiative led by Dr. Robert Rey, known to television audiences as "Dr. 90210," as he returns to a greater public and professional role focused on physician education, surgical training and patient-centered care. Dr. Robert Rey, PRM Cosmetic Surgery. After stepping away from the public eye while undergoing treatment for cancer, Dr. Rey has fully recovered and is returning with a renewed...

Read more
VSee Health Poised for Growth
Healthcare & PharmaceuticalShareholder Meeting

VSee Health Poised for Growth

August 27, 2026 9:30 AM

VSee Health, Inc. (NASDAQ:VSEE) (the "Company"), a provider of telehealth services and technology, announced that it has identified approximately $1 million in near term annual savings associated with its transition from Nasdaq, the reduction of public-company expenses and the streamlining of its corporate operations. The Company intends to redirect these savings toward revenue-generating growth initiatives, working capital and the continued...

Read more
CNS Pharmaceuticals Participates in the Virtual Investor
Healthcare & PharmaceuticalCompany Update

CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference

August 27, 2026 9:01 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biotechnology company focused on building a pipeline of innovative therapies addressing significant unmet medical needs, today announced that it participated in the Virtual Investor "Why Now" on-demand conference. Rami Levin, President and Chief Executive Officer of CNS Pharmaceuticals, highlighted the Company's strategic transformation that is being built on the strength of its...

Read more
DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)
Healthcare & PharmaceuticalProduct Announcements

DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)

August 27, 2026 8:55 AM

DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx™ combined with blockchain-enabled smart contracts platform PharmacyChain™ to provide integrated solutions for the tokenization of pharmaceutical serialization and the compliant delivery of healthcare and monetization of health data, today announced...

Read more
Reaching Beyond Distance: How Salta, Argentina Built a System for Stroke Care Equity
Healthcare & PharmaceuticalCompany Update

Reaching Beyond Distance: How Salta, Argentina Built a System for Stroke Care Equity

August 27, 2026 8:35 AM

When a real patient arrived during a stroke-response training exercise, clinicians didn't hesitate-they acted. That moment became early proof that Salta Stroke 360° wasn't just preparing teams for emergencies but building a system ready to respond when every second matters. When training turns into reality It was supposed to be a simulation. Clinicians participating in a stroke-response training exercise were running through different possible...

Read more
Valion Bio Announces Reverse Stock Split
Healthcare & PharmaceuticalCompany Update

Valion Bio Announces Reverse Stock Split

August 27, 2026 8:30 AM

Valion Bio, Inc. (Nasdaq:VBIO) ("Valion Bio" or the "Company) announced today that its Board of Directors has declared a 1-for-25 reverse stock split of the Company's issued and outstanding shares of common stock. The purpose of the reverse stock split is to bring the Company into compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market ("Nasdaq"). The reverse stock split was approved by the...

Read more
The Hidden Cost of Fragmented Contracts in Community Hospitals
Healthcare & PharmaceuticalAdvertorial

The Hidden Cost of Fragmented Contracts in Community Hospitals

August 27, 2026 8:00 AM

Community hospitals run on contracts. Payer agreements, vendor terms, credentialing requirements, supply arrangements, compliance obligations, all of it is contract-driven. And for most small and mid-sized hospitals, those contracts live in three different places: a shared drive no one fully trusts, an email thread from 18 months ago, and someone's desk drawer. That fragmentation has a price. Industry research from World Commerce and Contracting...

Read more
Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes
Healthcare & PharmaceuticalFinancing

Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes

August 27, 2026 7:20 AM

Moderna, Inc. (NASDAQ:MRNA) ("Moderna"), today announced that it intends to offer, subject to market conditions and other factors, $2.0 billion aggregate principal amount of Convertible Senior Notes due 2032 (the "notes") in a private placement (the "offering") only to persons reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Moderna also intends...

Read more
The Economics of Healthcare Have Changed
Healthcare & PharmaceuticalCompany Update

The Economics of Healthcare Have Changed

August 27, 2026 7:00 AM

Employer healthcare costs are projected to rise 9.5% in 2027, pushing average costs above $19,000 per employee, according to Aon. Against those economics, it is hardly surprising that only 27% of large firms offering health benefits offered them to part-time workers in 2025, according to KFF. But while the cost of health insurance continues to climb at a record pace, innovation and technology have changed the economics of healthcare itself. The...

Read more
AlzeCure Pharma to Present at The Pareto Securities 17th Annual Healthcare Conference on September 2
Healthcare & PharmaceuticalCompany Update

AlzeCure Pharma to Present at The Pareto Securities 17th Annual Healthcare Conference on September 2

August 27, 2026 4:25 AM

AlzeCure Pharma AB ("AlzeCure" or "The Company") (STO:ALZCUR)(FRA:AC6), which develops small-molecule drug candidates for CNS diseases with a focus on Alzheimer's disease and pain, announced today that it will participate in the Pareto Securities 17th Annual Healthcare Conference on September 2, where CEO Martin Jönsson will give a company presentation and answer questions about the latest developments and AlzeCure's plans for the future. Venue:...

Read more
Bionic Bloom Integrated Health Welcomes Erica Veno, MSW, RCSWI, as New Therapy Provider
Healthcare & PharmaceuticalCompany Update

Bionic Bloom Integrated Health Welcomes Erica Veno, MSW, RCSWI, as New Therapy Provider

August 26, 2026 5:50 PM

Bloom Integrated Health, home to Bionic Bloom and the Neurodivergent Empowerment Institute (NEI), today announced that St. Petersburg-based Erica Veno, MSW, RCSWI, has joined its expanding team of therapy providers. Veno brings more than 10 years of behavioral-health experience across inpatient and outpatient mental-health and substance-use treatment settings. Her background includes individual and group therapy, crisis intervention, treatment...

Read more
Blueberries Medical Announces Closing of C$1.1 Million Non-Brokered Private Placement
Healthcare & PharmaceuticalFinancing

Blueberries Medical Announces Closing of C$1.1 Million Non-Brokered Private Placement

August 26, 2026 4:30 PM

Blueberries Medical Corp. (CSE:BBM)(OTCID:BBRRF)(FRA:1OA) (the "Company" or "Blueberries"), a consumer science company focused on health, wellness and longevity, and a licensed producer of both psychoactive and non-psychoactive cannabis derivatives in Colombia, announces a non-brokered private placement consisting of the sale of 84,615,385 common shares ("Common Shares") at a price of C$0.013 per Common Share for aggregate gross proceeds of...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?